Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PMGM

Priveterra Acquisition Corp. II

Apr 26 • 03:19PM ET

11.17

Dollar change +0.12
Percentage change 1.09	%

Financial • Shell Companies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	130.95	EPS (ttm)	0.09	Insider Own	78.21%	Shs Outstand	8.82M	Perf Week	1.36%
Market Cap	98.52M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.92M	Perf Month	1.18%
Income	1.00M	PEG	-	EPS next Q	-	Inst Own	20.65%	Short Float	0.03%	Perf Quarter	3.91%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	17.95%	Short Ratio	0.74	Perf Half Y	8.24%
Book/sh	0.70	P/B	15.87	EPS next Y	-	ROA	0.67%	Short Interest	0.00M	Perf Year	12.15%
Cash/sh	0.00	P/C	2462.99	EPS next 5Y	-	ROE	0.74%	52W Range	10.38 - 11.23	Perf YTD	1.64%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	16.18%	52W High	-0.53%	Beta	0.02
Dividend TTM	-	Quick Ratio	0.02	Sales past 5Y	-	Gross Margin	-	52W Low	7.61%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	0.02	EPS Y/Y TTM	-74.54%	Oper. Margin	0.00%	RSI (14)	63.12	Volatility	0.02% 0.06%
Employees	-	Debt/Eq	0.10	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-800.90%	Payout	-	Rel Volume	0.00	Prev Close	11.05
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	0.87K	Price	11.17
SMA20	1.17%	SMA50	2.08%	SMA200	6.06%	Trades		Volume	1	Change	1.09%

Jul-24-23 07:00AM	AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update (GlobeNewswire)
Jul-21-23 04:27PM	Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc. (Business Wire)
Jul-17-23 05:02PM	Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc. (Business Wire)
Jul-11-23 06:40PM	Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc. (Business Wire)
Jun-30-23 08:00AM	AEON Biopharma and Priveterra Announce Arrangement of Up to $125 Million of Financing in Connection with Proposed Business Combination (GlobeNewswire)

Priveterra Acquisition Corp. II is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on August 10, 2020 and is headquartered in Irvine, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PMGM

Priveterra Acquisition Corp. II

Upgrade your FINVIZ experience